I can't and won't argue that Leo made a good deal for himself. But I'll settle in comfortably for the argument that Leo has mixed quite a lot of work into his play. Leo hasn't been freeloading off my dime, nor yours. The clinical trial progression of CTIX is impeccable and comparatively rapid - that doesn't happen through the toil of south Florida elves while Leo sleeps. Leo is purely in the bidness of clinical trial progression of new drugs. That is his product. My company makes and sells millions of one thing, one product, every day. A successful CEO in Leo's business sells one product, one thing, every few years. I think we're getting close to one of those events in CTIX's case. Buck up.
Market Data 
Markets 
AI
